Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04310592
Title Natural Killer Cell (CYNK-001) Infusions in Adults With AML (CYNK001AML01)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celularity Incorporated
Indications

acute myeloid leukemia

Therapies

Cyclophosphamide + Fludarabine

CYNK-001

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Colorado Blood Cancer Institute Recruiting Denver Colorado 80218 United States Details
University of Chicago Recruiting Chicago Illinois 60637 United States Details
Hackensack University Medical Center Recruiting Hackensack New Jersey 07601 United States Details
Roswell Park Comprehensive Cancer Center Recruiting Buffalo New York 14203 United States Details
Columbia University and New York Presbyterian Hospital Recruiting New York New York 10032 United States Details
Memorial Sloan Kettering Cancer Center Active, not recruiting New York New York 10065 United States Details
Tennessee Oncology Recruiting Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Not yet recruiting Houston Texas 77030 United States Details
Swedish Health Services Recruiting Seattle Washington 98122 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field